rs555607708
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs587778134
|
|
CAA |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs587779018
|
|
CT |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs587779021
|
|
C |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs587779157
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs587780226
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs587782705
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs63750206
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs63750547
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs63750691
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs63750767
|
|
TTCAAAAGGGACATAGAAAA |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs63750781
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs63751207
|
|
C |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs864622607
|
|
G |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs869312768
|
|
CTT |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs869312770
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs869312775
|
|
G |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs869312781
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs869312783
|
|
ATTAG |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs989026404
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
|
|
|
rs1801155
|
|
|
0.800 |
GeneticVariation |
BEFREE |
Significantly, of the 12 individuals who possessed the I1307K mutation, none was diagnosed with colorectal cancer and none had a known first-, second-, or third-degree relative diagnosed with colon cancer.
|
9407954 |
1997 |
rs1463038513
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Significantly, of the 12 individuals who possessed the I1307K mutation, none was diagnosed with colorectal cancer and none had a known first-, second-, or third-degree relative diagnosed with colon cancer.
|
9407954 |
1997 |
rs1364898025
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Four distinct sequence alterations were identified: (a) in one gastric and one esophageal tumor, an A to C transversion occurred at nucleotide 5795 (CAC-->CCC), leading to a His-->Pro substitution at codon 179; (b) a second esophageal tumor had a C to T transition at nucleotide 8291 (ACC-->ATC), leading to a Thr-->Ile substitution at codon 277 of IGFBP-3; (c) one alteration comprised a G to C transversion in exon 1 at nucleotide 2132 (GGG-->GCG), leading to a Gly-->Ala substitution at codon 32 in two gastric cancers, seven esophageal cancers, and nine colon cancers; and (d) a C to G transversion located 17 nucleotides from the 3' splice site in intron 1 was observed in three colon cancers and four esophageal cancers.
|
9809981 |
1998 |
rs145188037
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Four distinct sequence alterations were identified: (a) in one gastric and one esophageal tumor, an A to C transversion occurred at nucleotide 5795 (CAC-->CCC), leading to a His-->Pro substitution at codon 179; (b) a second esophageal tumor had a C to T transition at nucleotide 8291 (ACC-->ATC), leading to a Thr-->Ile substitution at codon 277 of IGFBP-3; (c) one alteration comprised a G to C transversion in exon 1 at nucleotide 2132 (GGG-->GCG), leading to a Gly-->Ala substitution at codon 32 in two gastric cancers, seven esophageal cancers, and nine colon cancers; and (d) a C to G transversion located 17 nucleotides from the 3' splice site in intron 1 was observed in three colon cancers and four esophageal cancers.
|
9809981 |
1998 |
rs2854746
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Four distinct sequence alterations were identified: (a) in one gastric and one esophageal tumor, an A to C transversion occurred at nucleotide 5795 (CAC-->CCC), leading to a His-->Pro substitution at codon 179; (b) a second esophageal tumor had a C to T transition at nucleotide 8291 (ACC-->ATC), leading to a Thr-->Ile substitution at codon 277 of IGFBP-3; (c) one alteration comprised a G to C transversion in exon 1 at nucleotide 2132 (GGG-->GCG), leading to a Gly-->Ala substitution at codon 32 in two gastric cancers, seven esophageal cancers, and nine colon cancers; and (d) a C to G transversion located 17 nucleotides from the 3' splice site in intron 1 was observed in three colon cancers and four esophageal cancers.
|
9809981 |
1998 |